Video: Enumeral Aspires To Take PD-1 Inhibition To The Next Level
This article was originally published in The Pink Sheet Daily
Executive Summary
In an interview at the recent Biotech Showcase, CEO Arthur Tinkelenberg explains his company’s approach to developing the next generation of checkpoint inhibitors.